Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 39 Breast 3 Tumor-Agnostic 2 Plasma cell 2 Thoracic 1 Sarcoma 1

Conditions

Prostatic Neoplasms 1 Bone Neoplasms 1

Interventions

Doxorubicin 44 Imatinib Mesylate 33 pembrolizumab 23 Cyclophosphamide 23 Sunitinib 22 Gemcitabine 22 Temozolomide 17 Irinotecan 14 Bevacizumab 14 Docetaxel 13 nilotinib 12 Trabectedin 12 ripretinib 11 pazopanib 11 olaratumab 10 fludarabine 10 eribulin 10 regorafenib 9 avapritinib 9 Fluorouracil 9 Carboplatin 9 Paclitaxel 8 Nivolumab 8 Ifosfamide 8 Ibandronic Acid 8 spartalizumab 7 anlotinib 7 Vincristine 7 Radiation 7 Ipilimumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × radium Ra 223 dichloride × Sarcoma × Clear all

NCT04681144 2023-10-26

QOLRAD

Bayer

GenitourinarySarcoma

Bone Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡